Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iNeo-Vac-T01 in Advanced Hepatocellular Carcinoma
NCT07123545Phase 2Recruiting
- Sponsor
- Zhejiang University
- Start
- Aug 2025
- Primary completion
- Jul 2027
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of iNeo-Vac-T01 in hepatocellular carcinoma (HCC), sponsored by Zhejiang University. Started Aug 2025; status: recruiting.
02
Drugs
iNeo-Vac-T01
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT07123545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07123545.